Metformin blocks the tumour-promoting effects of NGF in EOC cells modulating several oncoproteins such as VEGF, c-MYC and survivin, as well as c-MYC and β-catenin/TCF-Lef transcriptional activity. The gene discussed is MYC; the disease is neoplasm.